Clinitech Laboratory Share Price
35.10+0.00 (+0.00%)
-21.65% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
APOLLOHOSP-ANSE
MAXHEALTH-ANSE
FORTIS-ANSE
ASTERDM-ANSE
MEDANTA-ANSE
NH-ANSE
KIMS-ANSE
LALPATHLAB-ANSE
VIJAYA-ANSE
AGARWALEYE-ANSE
CTLLAB-MNSE
Clinitech Laboratory Share Price
35.10+0.00 (+0.00%)
-21.65% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | 9% | 29% |
| - | - | -8% | 6% |
| - | - | - | - |
| 22% | 22% | 16% | 6% |
Peer Comparison
Symbol
APOLLOHOSP-A
MAXHEALTH-A
FORTIS-A
ASTERDM-A
MEDANTA-A
NH-A
KIMS-A
LALPATHLAB-A
VIJAYA-A
AGARWALEYE-A
CTLLAB-M
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 8,900 | ₹130273 Cr | 62.35 | 40.39 | 207.67 | ₹1942 Cr |
| 1,047.5 | ₹102446 Cr | 70.32 | 3.31 | 19.84 | ₹1442 Cr |
| 878.75 | ₹67267 Cr | 64.19 | 3.53 | 20.1 | ₹1042 Cr |
| 770.55 | ₹66295 Cr | 208.03 | 0.31 | 6.76 | ₹388 Cr |
| 1,502.25 | ₹40209 Cr | 72.3 | 5.91 | 29.85 | ₹556 Cr |
| 1,879.55 | ₹39270 Cr | 48.12 | 10.14 | 65.36 | ₹806 Cr |
| 802 | ₹33529 Cr | 164.12 | 1.04 | 12.74 | ₹241 Cr |
| 1,958.8 | ₹32271 Cr | 59.55 | 10.11 | 42.51 | ₹505 Cr |
| 1,531 | ₹16149 Cr | 86.13 | 5.16 | 27.53 | ₹173 Cr |
| 503 | ₹15713 Cr | 105.91 | 1.43 | 13.88 | ₹133 Cr |
| 35.1 | ₹8 Cr | 18.94 | 0.52 | 4.09 | ₹42 L |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|
| — | — | — | — | — |
| ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹67 L |
| ₹7 Cr | ₹2 Cr | ₹88 L | ₹35 L | ₹72 L |
| ₹7 Cr | ₹2 Cr | ₹88 L | ₹35 L | ₹72 L |
| ₹9 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr |
| ₹0 | ₹23 L | ₹28 L | ₹36 L | ₹48 L |
| -₹17 L | -₹17 L | -₹16 L | -₹11 L | -₹9 L |
| ₹0 | ₹0 | ₹1 Cr | ₹0 | ₹0 |
| ₹20 L | ₹19 L | ₹12 L | ₹12 L | ₹10 L |
| ₹3 L | ₹26 L | ₹2 Cr | ₹37 L | ₹49 L |
| — | — | — | — | — |
| ₹63 L | ₹35 L | ₹40 L | ₹52 L | ₹46 L |
| ₹70 L | ₹51 L | ₹12 L | ₹13 L | ₹10 L |
| ₹0 | ₹58 L | ₹67 L | ₹46 L | ₹39,000 |
| ₹35 L | ₹20 L | ₹56 L | ₹26 L | ₹20 L |
| ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹77 L |
| ₹11 Cr | ₹5 Cr | ₹6 Cr | ₹4 Cr | ₹3 Cr |
| ₹0 | ₹86 L | ₹1 Cr | ₹89 L | ₹54 L |
| — | — | — | — | — |
| ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹2 Cr |
| ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹84 L |
| ₹0 | ₹0 | ₹56 L | ₹41 L | ₹8 L |
| ₹7 L | ₹7 L | ₹2 Cr | ₹14 L | ₹9 L |
| ₹7 L | ₹7 L | ₹2 Cr | ₹14 L | ₹9 L |
| ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹2 Cr | ₹1 Cr |
| — | — | — | — | — |
| ₹53 L | ₹28 L | ₹14 L | ₹16 L | ₹9 L |
| ₹2 Cr | ₹60 L | ₹49 L | ₹36 L | ₹56 L |
| ₹3 Cr | ₹70 L | ₹78 L | ₹10 L | ₹32 L |
| ₹2 L | ₹3 L | ₹12 L | ₹23 L | ₹5 L |
| ₹2 Cr | ₹1 Cr | ₹43 L | ₹53 L | ₹61 L |
| ₹7 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr |
| ₹6 Cr | ₹1 Cr | ₹21 L | ₹2 L | ₹86 L |
| ₹11 Cr | ₹5 Cr | ₹6 Cr | ₹4 Cr | ₹3 Cr |
| ₹39 | ₹21 | ₹16 | ₹12 | ₹21 |
| ₹39 | ₹21 | ₹16 | ₹12 | ₹9 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|
| ₹55 L | ₹51 L | ₹86 L | ₹70 L | ₹55 L |
| ₹29 L | ₹50 L | ₹41 L | ₹31 L | ₹17 L |
| -₹2 Cr | -₹2 Cr | ₹28 L | ₹15 L | -₹18 L |
| -₹72 L | -₹1 Cr | ₹2 Cr | ₹1 Cr | ₹53 L |
| -₹88 L | -₹1 Cr | ₹1 Cr | ₹96 L | ₹38 L |
| -₹73 L | ₹75 L | -₹65 L | -₹1 Cr | ₹54 L |
| ₹4 Cr | ₹45 L | ₹9 L | ₹29 L | -₹88 L |
| ₹2 Cr | -₹8 L | ₹68 L | -₹22 L | ₹4 L |
| ₹70 L | ₹78 L | ₹10 L | ₹32 L | ₹28 L |
| ₹3 Cr | ₹70 L | ₹78 L | ₹10 L | ₹32 L |
Fundamental Ratios
Consolidated
Standalone
Clinitech Laboratory Share Price
35.10+0.00 (+0.00%)
-21.65% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 5 out of 9 oscillators
RSI
40.20Sell
STOCH %K
1.54Buy
MACD Level(12,26)
-1.16Sell
Ultimate Oscillator
24.43Sell
Aroon Oscillator
14.00Sell
BOP
0.00Neutral
CCI
-125.54Buy
Williams %R
-98.46Buy
Momentum
-6.90Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 0
Bearish signals: 9 out of 9 moving averages
EMA 9
36.74Sell
SMA 9
36.98Sell
EMA 21
38.19Sell
SMA 21
39.34Sell
EMA 50
39.15Sell
SMA 50
38.93Sell
EMA 200
50.51Sell
SMA 200
46.38Sell
WMA 20
38.07Sell
Pivot
Pivot
Classic
Resistance 5
35.10
Resistance 4
35.10
Resistance 3
35.10
Resistance 2
35.10
Resistance 1
35.10
Pivot
35.10
Support 1
35.10
Support 2
35.10
Support 3
35.10
Support 4
35.10
Support 5
35.10
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Clinitech Laboratory Share Price
35.10+0.00 (+0.00%)
-21.65% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Mar 2026 | Sep 2025 | Mar 2025 | Sep 2024 |
|---|---|---|---|
| 64.20% | 62.42% | 61.58% | 61.58% |
| 0.32% | 0.32% | 0.32% | 0.32% |
| 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% |
| 35.48% | 37.26% | 38.10% | 38.10% |
Bulk & block deals
Name
Vorton Opportunities Fund
Siddharth Bipinbhai Mehta
Mukesh Keshubhai Thumar
Binaben Bipinkumar Mehta
Sanjay Harshadrai Mehta
Sanjay Harshadrai Mehta
Rahul R Mahajan
Binaben Bipinkumar Mehta
Bonanza Portfolio Limited
Kripananda Chidambaram
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 16 Apr 2026 | Purchase | 6.41 L | ₹44.52 | 14.40 K | Bulk | 0.630915 | BSE |
| 23 Mar 2026 | Purchase | 3.98 L | ₹33.20 | 12 K | Bulk | 0.525762 | BSE |
| 23 Mar 2026 | Sell | 5.54 L | ₹32.95 | 16.80 K | Bulk | 0.736067 | BSE |
| 23 Mar 2026 | Sell | 3.98 L | ₹33.20 | 12 K | Bulk | 0.525762 | BSE |
| 17 Mar 2026 | Sell | 6 L | ₹33.34 | 18 K | Bulk | 0.788644 | BSE |
| 29 Jan 2026 | Purchase | 5.04 L | ₹32.32 | 15.60 K | Bulk | 0.683491 | BSE |
| 29 Jan 2026 | Sell | 3.54 L | ₹29.54 | 12 K | Bulk | 0.525762 | BSE |
| 17 Nov 2025 | Purchase | 5.30 L | ₹40.15 | 13.20 K | Bulk | 0.578339 | BSE |
| 19 Aug 2025 | Purchase | 8.89 L | ₹52.92 | 16.80 K | Bulk | 0.736067 | BSE |
| 19 Aug 2025 | Sell | 8.26 L | ₹52.97 | 15.60 K | Bulk | 0.683491 | BSE |
Insider trading & SAST
Client name
Jagdish Nayak & Pacs
Jagdish Umakant Nayak
Jagdish Umakant Nayak & Pacs
Siddhesh Nayak & Pacs
Jagdish Umakant Nayak
Jagdish Umakant Nayak & Pacs
Jagdish Umakant Nayak
Jagdish Umakant Nayak & Pacs
Siddhesh Anant Nayak & Pacs
Mr. Jagdish Umakant Nayak
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 Apr 2026 | Promoter | Acquisition | 0.42 | 64.62 | 0 | — | 9.60 K | 30 Mar 2026 | Market | 14,75,000 | SAST | 29(2) | — |
| 10 Apr 2026 | Promoter | Acquisition | 0.37 | 30.92 | 0 | — | 8.40 K | 11 Mar 2026 | Market | 7,05,700 | SAST | 29(2) | — |
| 10 Apr 2026 | Promoter | Acquisition | 0.21 | 63.99 | 0 | — | 4.80 K | 19 Mar 2026 - 20 Mar 2026 | Market | 14,60,600 | SAST | 29(2) | — |
| 10 Apr 2026 | Promoter | Acquisition | 0.05 | 64.2 | 0 | — | 1.20 K | 27 Mar 2026 | Market | 14,65,400 | SAST | 29(2) | — |
| 10 Apr 2026 | Promoter | Acquisition | 0.16 | 30.55 | 0 | — | 3.60 K | 10 Mar 2026 | Market | 6,97,300 | SAST | 29(2) | — |
| 10 Apr 2026 | Promoter | Acquisition | 0.21 | 63.78 | 0 | — | 4.80 K | 17 Mar 2026 - 18 Mar 2026 | Market | 14,55,800 | SAST | 29(2) | — |
| 10 Apr 2026 | Promoter | Acquisition | 0.26 | 31.18 | 0 | — | 6 K | 12 Mar 2026 - 13 Mar 2026 | Market | 7,11,700 | SAST | 29(2) | — |
| 10 Apr 2026 | Promoter | Acquisition | 0.05 | 64.15 | 0 | — | 1.20 K | 25 Mar 2026 | Market | 14,64,200 | SAST | 29(2) | — |
| 10 Apr 2026 | Promoter | Acquisition | 0.11 | 64.1 | 0 | — | 2.40 K | 24 Mar 2026 | Market | 14,63,000 | SAST | 29(2) | — |
| 30 Mar 2026 | Promoter & Director | Acquisition | 0.42061 | 32.08 | 3.36 L | ₹35 | 9.60 K | 30 Mar 2026 | Market Purchase | 7,32,100 | Insider Trading | — | Equity Shares |
Clinitech Laboratory Share Price
35.10+0.00 (+0.00%)
-21.65% past 1 Year
Clinitech Laboratory is one of the most trusted diagnostic centers & pathology labs. The company is a provider of diagnostic and healthcare tests and services through chain of several diagnostic
Corporate Actions
Date
Type
Details
Company details
Clinitech Laboratory Share Price
35.10+0.00 (+0.00%)
-21.65% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Clinitech Laboratory Share Price
35.10+0.00 (+0.00%)
-21.65% past 1 Year
News
Clinitech Laboratory informs about disclosure
Equity
CTLLAB
Clinitech Laboratory signs MoU with MD Plus Multispeciality Clinic
Equity
CTLLAB
Clinitech Laboratory informs about disclosure
Equity
CTLLAB
Clinitech Laboratory enters into MoU with M/s. MDM Dawudi Hospital
Equity
CTLLAB
Clinitech Laboratory informs about updates
Equity
CTLLAB
Clinitech Laboratory enters into Service Agreement with QB
Equity
CTLLAB
Clinitech Laboratory informs about disclosure
Equity
CTLLAB
Clinitech Laboratory informs about RTA certificate
Equity
CTLLAB
Clinitech Laboratory informs about board meeting
Equity
CTLLAB
Clinitech Laboratory opens new collection centre in Maharashtra
Equity
CTLLAB
Clinitech Laboratory informs about new collection centre
Equity
CTLLAB


